Completed PHASE1 INTERVENTIONAL 4-arm NCT02714842

Delayed Release Diclofenac Sodium Formulation vs Voltaren®

A Pharmacoscintigraphic Clinical Study to Investigate the in Vivo Behaviour of a Novel Delayed-release Formulation of Diclofenac in Comparison to the Voltaren® Enteric Coated Tablet Commercial Formulation in Healthy Volunteers

Sponsor: BDD Pharma Ltd

Conditions Pain

Interventions Diclofenac Radiolabelled Diclofenac Tablet A Radiolabelled Diclofenac tablet B Radiolabelled Diclofenac tablet C

Updated 7 times since 2017 Last updated: Sep 27, 2016 Started: Mar 31, 2016 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Pain, this trial is completed. The trial is conducted by BDD Pharma Ltd and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2018 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Feb 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BDD Pharma Ltd
Drug Delivery International Ltd

Data source: BDD Pharma Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glasgow, United Kingdom